1. Home
  2. HDRN vs HURA Comparison

HDRN vs HURA Comparison

Compare HDRN & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hadron Energy Inc. Common Stock

HDRN

Hadron Energy Inc. Common Stock

SELL

Current Price

$0.75

Market Cap

148.0M

Sector

Utilities

ML Signal

SELL

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$2.18

Market Cap

160.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDRN
HURA
Founded
2024
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
148.0M
160.5M
IPO Year
2024
2010

Fundamental Metrics

Financial Performance
Metric
HDRN
HURA
Price
$0.75
$2.18
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.04
AVG Volume (30 Days)
83.3K
★ 250.0K
Earning Date
11-08-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.93
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.41
52 Week High
$2.67
$3.43

Technical Indicators

Market Signals
Indicator
HDRN
HURA
Relative Strength Index (RSI) 26.14 59.70
Support Level N/A $2.06
Resistance Level $2.03 $2.22
Average True Range (ATR) 0.12 0.13
MACD 0.00 0.03
Stochastic Oscillator 20.90 92.86

Price Performance

Historical Comparison
HDRN
HURA

About HDRN Hadron Energy Inc. Common Stock

Hadron Energy Inc is a nuclear technology company focused on developing factory-fabricated, transportable 10 megawatt-electric (MWe) micro-modular reactors (MMRs) to meet the growing demand for clean, reliable, and affordable power. The company aims to deliver scalable, carbon-free energy solutions that can be rapidly deployed to power a variety of industries, including data centers, industrial facilities, remote communities, government installations and more. The market segments for its proprietary reactor, Hadron Halos, are Data Centers, Industrial Facilities and Heavy Manufacturing, Remote Communities and Critical Infrastructure, and Utilities and Distributed Energy.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Share on Social Networks: